Iron deficiency anemia and cardiac mortality in patients with left ventricular systolic dysfunction undergoing coronary stenting

Minerva Cardioangiologica

Volumn 58, Issue 1, 2010, Pages 1-10

  Varma, A ^a   Appleton, D L ^a   Nusca, A ^b   Lipinski, M J ^c   Goudreau, E ^a   Cowley, M J ^a   Wittkamp, M ^a   Vetrovec, G W ^a   Abbate, A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Anemia, iron deficiency; Mortality; Ventricular dysfunction, left

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY STENT; DISEASE ASSOCIATION; FEMALE; HEART DEATH; HEART EJECTION FRACTION; HEART LEFT VENTRICLE CONTRACTION; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SYSTOLIC DYSFUNCTION;

AGED; ANEMIA, IRON-DEFICIENCY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; STENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77952341576     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Nikolsky E, Mehran R, Aymong E, Mintz GS, Lansky AJ, Lasic Z et al. Impact of anemia on outcomes of patients undergoing percutaneous coronary intervention. Am J Cardiol 2004;94:1023-1027 (Pubitemid 39336435)
2. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006;48:2485-2489
3. Reinecke H, Trey T, Wellmann J, Heidrich J, Fobker M, Wichter T et al. Haemoglobin-related mortality in patients undergoing percutaneous coronary intervention. Eur Heart J 2003;24:2142-2150
4. McKechnie RS, Smith D, Montoye C, Kline-Rogers E, O'Donnell MJ, DeFranco AC et al. Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary interventions. Circulation 2004;110:271-277
5. Lee PC, Annapoorna SK, Ahsan C, Fisher E, Sharma SK. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 2004;44:541-546
6. Nikolsky E, Aymong ED, Halkin A, Grines C, Cox D, Garcia E et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous intervention. Analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. J Am Coll Cardiol 2004;44:547-553 (Pubitemid 39078177)
7. Kannel WB. Epidemiology and prevention of cardiac failure: Framingham study insights. Eur Heart J 1987;8 (Suppl)F23-9.
8. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol 2003;41:1933-1939.
9. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003;107:223-5.
10. Horwich TB, Fonarow GC, Hamilton MA, MacLellam WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-6.
11. Szachniewicz J, Petruk-Kowalczyk J, Majda J, Kaczmarek A, Reczuch K, Kalra PR et al. Anemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 2003;90:303-308
12. Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004;110:149-154
13. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med 2003;114:112-119 (Pubitemid 36183592)
14. Sharma R, Francis DP, Pitt B, Poole-Wilson PA, Coats AJ, Anker SD. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J 2004;25:1021-1028
15. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis 2001;37:S182-S238.
16. Wahr JA. Myocardial ischemia in anemic patients. Br J Anaesth 1998;81(Suppl 1):10-15
17. Sabatine MS, Morrow DA, Giugliano RP, Burton PBJ, Murphy SA, McCabe CH et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005;111:2042-2049
18. Herrera-Garza EH, Stetson SJ, Cubillos-Garzon A, Vooltich MT, Farmer JA, Torre-Amione G. Tumor necrosis factor: a mediator of disease progression in the failing human heart. Chest 1999;115:1170-1174
19. Bolger AP, Doehner W, Sharma R, Coats AJ, Anker S. Anemia in chronic heart failure: the relationship to inflammatory cytokine production and prognostic importance. Circulation 2002;106(Suppl):2819A.
20. Yoshikawa H, Powell WJ Jr, Bland JH, Lowenstein E. Effect of acute anemia on experimental myocardial ischemia. Am J Cardiol 1973;32:670-678
21. Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 2005;26:2232-2237
22. Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program 2006;507:29-35.
23. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-1023
24. Vaziri ND. Erythropoietin and transferrin metabolism in nephrotic syndrome. Am J Kidney Dis 2001;38:1-8.
25. Chatterjee B, Nydegger UE, Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE inhibitors or AT1 antagonists. Eur J Heart Fail 2000;2:393-8.
26. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38:955-62.
27. Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using sub- cutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001;37:1775-80.
28. Bolger AP, Bartlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006;48:1225-1227
29. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000;35:1737-1744
30. Okonko DO, Grzeslo A, Withowski T, Mandal AK, Slater RM, Roughton M et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and non-anemic patients with symptomatic chronic heart failure and iron deficiency: FERRIC-HF: A randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008;51:103-112
31. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230-6.
32. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW et al. Relationship of blood transfusions and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-1562
33. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA et al. Impart of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007;116:471-479
34. Lipinski MJ, Martin RE, Cowley MJ, Goudreau E, Malloy WN, Vetrovec GW. Improved survival for stenting vs. balloon angioplasty for the treatment of coronary artery disease in patients with ischemic left ventricular dysfunction. Catheter Cardiovasc Interv 2005;66:547-553